Skip to main content
. Author manuscript; available in PMC: 2021 Oct 30.
Published in final edited form as: Nutr Metab Cardiovasc Dis. 2020 Jun 29;30(11):2077–2084. doi: 10.1016/j.numecd.2020.06.015

Table 3.

Branched-chain amino acid metabolites, history of gestational diabetes, and breastfeeding

history of gestational diabetes any diabetes during pregnancy ever breastfed >6 months breastfeeding
beta 95% CI beta 95% CI beta 95% CI beta 95% CI
1-carboxyethylisoleucinea, b 0.1937 −0.0161, 0.4036 0.2950 0.0801, 0.5098 −0.1729 −0.3160, −0.0297 −0.2722 −0.4648, −0.0795
1-carboxyethylleucinea, b 0.2909 0.0732, 0.5085 0.3253 0.1111, 0.5395 −0.1425 −0.2858, 0.0008 −0.2636 −0.4562, −0.0710
2,3-dihydroxy-2-methylbutyratea,b 0.0452 −0.2094, 0.2997 0.0521 −0.1866, 0.2908 −0.0872 −0.2463, 0.0718 −0.1522 −0.3664, 0.0621
2-hydroxy-3-methylvaleratea 0.0469 −0.1711, 0.2648 0.0414 −0.1626, 0.2453 −0.1713 −0.3067, −0.0360 −0.2189 −0.4014, −0.0364
3-hydroxyisobutyratea 0.1672 −0.0872, 0.4215 0.1363 −0.1035, 0.3761 0.1532 −0.0063, 0.3126 −0.0305 −0.2460, 0.1851
3-methyl-2-oxovalerate 0.2312 −0.0050, 0.4675 0.2691 0.0454, 0.4927 −0.0337 −0.1834, 0.1160 −0.1005 −0.3022, 0.1013
3-methylglutaconatea 0.2794 0.0159, 0.5429 0.1902 −0.0565, 0.4368 0.0047 −0.1599, 0.1694 0.0110 −0.2110, 0.2392
3-methylglutarylcarnitine (2)a 0.0952 −0.1403, 0.3307 0.0157 −0.2052, 0.2366 −0.0164 −0.1638, 0.1309 0.0523 −0.1462, 0.2507
4-methyl-2-oxopentanoate 0.1955 −0.0442, 0.4351 0.2406 0.0139, 0.4674 0.0300 −0.1217, 0.1816 0.0298 −0.1747,0. 2342
alpha-hydroxyisovaleratea 0.0807 −0.1667, 0.3282 0.0575 −0.1738, 0.2887 −0.1645 −0.3182, −0.0108 −0.1948 −0.4021, 0.0124
beta-hydroxyisovaleratea −0.0643 −0.3187, 0.1902 −0.0544 −0.2924, 0.1836 −0.1169 −0.2754, 0.0416 −0.1132 −0.3271, 0.1007
ethylmalonatea −0.0326 −0.2881, 0.2229 −0.0162 −0.2574, 0.2249 0.1317 −0.0289, 0.2921 0.0659 −0.1516, 0.28214
isobutyrylcarnitine (C4)a −0.0278 −0.2966, 0.2410 −0.0586 −0.3099, 0.1927 −0.0820 −0.2495, 0.0856 −0.1097 −0.3354, 0.1160
isobutyrylglycinea 0.0219 −0.2406, 0.2843 0.0138 −0.2323, 0.2598 −0.0775 −0.2415, 0.0864 −0.0040 −0.2251, 0.2170
isovalerate (i5:0) 0.0815 −0.1816, 0.3447 0.0868 −0.1596, 0.3332 0.0466 −0.1175, 0.2107 0.0125 −0.2088, 0.2338
isovalerylglycinea, b 0.1434 −0.1237, 0.4104 0.2068 −0.0427, 0.4562 −0.0613 −0.2279, 0.1054 −0.1619 −0.3862, 0.0624
methylsuccinatea 0.0228 −0.2347, 0.2830 0.0503 −0.1952, 0.2959 0.0964 −0.0670, 0.2599 −0.0272 −0.2476, 0.1933
N-acetylisoleucinea 0.1762 −0.0768, 0.4292 0.1582 −0.0784, 0.3948 −0.1330 −0.2906, 0.0247 −0.1398 −0.3505, 0.0746
N-acetylleucinea 0.2466 −0.0061, 0.4992 0.2020 −0.0341, 0.4382 −0.1779 −0.3350, −0.0207 −0.1534 −0.3658, 0.0590
tiglylcarnitine (C5:1-DC) 0.1173 −0.1314, 0.3660 0.0534 −0.1803, 0.2871 0.0989 −0.0568, 0.2546 0.1268 −0.0832, 0.3368
3-methyl-2-oxobutyrate 0.0598 −0.1805, 0.3002 0.1019 −0.1242, 0.3279 0.0283 −0.1225, 0.1791 −0.0524 −0.2557, 0.1509
isovalerylcarnitine (C5) −0.0795 −0.3414, 0.1822 −0.1049 −0.3497, 0.1399 0.0375 −0.1275, 0.2009 −0.0673 −0.2877, 0.1529
2-methylbutyrylcarnitine (C5) −0.0272 −0.2692, 0.2148 −0.0316 −0.2623, 0.1900 0.0033 −0.1475, 0.1541 −0.0899 −0.2931, 0.1132
1-carboxyethylvalinea, b 0.2827 0.0733, 0.4931 0.3512 0.1401, 0.5624 −0.1753 −0.3165, −0.0340 −0.2792 −0.4692, −0.0892
3-hydroxy-2-ethylpropionate 0.2767 0.0394, 0.5140 0.3308 0.1080, 0.5536 0.1779 0.0291, 0.3266 0.0936 −0.1079, 0.2951
alpha-hydroxyisocaproatea,b 0.2343 0.0027, 0.4660 0.2146 −0.0054, 0.4347 −0.1242 −0.2710, 0.0226 −0.3044 −0.5012, −0.1075
N-carbamoylvalinea, b 0.0254 −0.2278, 0.2786 0.0629 −0.1751, 0.3008 0.0757 −0.0829, 0.2344 0.0631 −0.1508, 0.2769

All results adjusted for age, BMI and waist circumference at time of metabolite measurement, average prior adult BMI, race, and menopausal status.

a

log-transformed to address skewness

b

>10% below the limit of detection; imputed as ½ LOD; results in supplementary material with values below LOD omitted